Epigenetic Alterations in Parathyroid Cancers
Parathyroid cancers (PCas) are rare malignancies representing approximately 0.005% of all cancers. PCas are a rare cause of primary hyperparathyroidism, which is the third most common endocrine disease, mainly related to parathyroid benign tumors. About 90% of PCas are hormonally active hypersecreti...
Main Authors: | Chiara Verdelli, Sabrina Corbetta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/2/310 |
Similar Items
-
The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
by: Fang Wang, et al.
Published: (2021-03-01) -
Anaesthetic Implications in Primary Hyperparathyroidism with Severe Hypercalcaemia; a Case Report
by: Pranav Bansal, et al.
Published: (2013-07-01) -
The Role of Epigenetics on Dental Implant Therapy: A Systematic Review
by: Riccardo Di Gianfilippo, et al.
Published: (2017-08-01) -
Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation
by: Apriliana E. R. Kartikasari, et al.
Published: (2019-01-01) -
Epigenetic Therapy in Lung Cancer
by: Stephen V Liu, et al.
Published: (2013-05-01)